Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (2136)	7/23/1998 8:17:00 AM
From: Robert Scott	Respond to of 4676

Heard on CNBC that ISIP is quoted at something like 18 on Instanet.

To: jackie who wrote (2136)	7/23/1998 2:42:00 PM
From: tom jones	Respond to of 4676

To all: ISIS 2922 and antisense. ISIS 2922 -the drug- works and the fda committee has approved it, not antisense -the technology or how the drug works-. Isis -the company- has not been able to show how the drug works. Call the company and ask them. Check reply 2146. It also was in some of the more informative new releases. Once Isis shows that a drug is working by antisense or put out 3 or 4 more drugs that work then you can say antisense works. I think antisense works but this does not mean it does. If antisense has been validated or proven 100% then Isis would have partners for all their drugs and the stock would be $100. Jim McCamant was not on KWHY-TV at 10:53 today his regular spot. Would have liked to hear what he has to say about Isis. Will check Mike Murphy Friday. Sometimes there is a delay before a stock goes up after good news (market makers covering their shorts and buying the stock). Tom